Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT03647111 · UNKNOWN
Trial details
- NCT number
- NCT03647111
- Sponsor
- Hunan Province Tumor Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-01
- Primary completion
- 2024-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.